Tuesday, March 27, 2012

Exposed: The Corporations Behind the Law That May Let Trayvon Martin's Killer Go Free | The Nation

Exposed: The Corporations Behind the Law That May Let Trayvon Martin's Killer Go Free | The Nation
According to the Center for Media and Democracy, 98 percent of ALEC’s revenues come from corporations, corporate trade groups, and corporate foundations. Each member pays annual fees of between $7,000 and $25,000. ALEC is also supplemented by direct grants. We don’t know all the details about all of ALEC’s funders and members. Here’s a partial list of what we do know about the corporations and foundations who helped fund the group that drafted the law that keeps Trayvon Martin’s killer free — and put more guns on our streets:
ALEC received $1.4 million in grants from ExxonMobil from 1998-2009.
It has also received grants from two Koch family-backed foundations: Charles G. Koch Foundation, the Claude R. Lambe Foundation.
ALEC has received grant money from the billionaire conservative and American Spectator publisher Richard Mellon Scaife‘s Allegheny Foundation and the Coors family’s Castle Rock Foundation.
ALEC’s Private Enterprise Board members include executives from Bayer Corp., GlaxoSmithKline, Centerpoint360, Reynolds American, Wal-Mart Stores, Johnson & Johnson, PhRMA, American Bail Coalition, Kraft Foods, Inc., Pfizer Inc., DIAGEO, AT&T, Reed Elsevier, Inc., Peabody Energy, UPS, Koch Companies Public Sector, LLC, Altria Client Services, ExxonMobil, Salt River Project, and State Farm Insurance Co. Coca Cola also recently had an executive on ALEC’s board.
According to reporting by my colleague, Lee Fang, ALEC’s 38th Annual Meeting was funded by corporations including BP, Takeda Pharmaceutical, Allergan, Altria, Bayer, Chevron, Peabody, Shell, UnitedHealthcare, Visa, FedEx, Louisiana Seafood, UPS, Amazon.com, Chesapeake Energy, ConocoPhillips, Dow, Gulf States Toyota, International Paper, TimeWarner, Wellpoint, HP, Lilly, Merck, USAA, and Walgreens (the full list available here). Read More Here | The Nation